Industry / India
Daiichi Sankyo Buys Controlling Stake In Ranbaxy
June 2008 | Company News AlertIn an effort to diversify and increase its presence in emerging markets, Japanese drugmaker Daiichi Sankyo has purchased a controlling stake in Indian generics firm Ranbaxy Laboratories. Closure of the deal is expected by March 2009 and the purchase price will be up to US$4.6bn.
Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.
If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.
If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.
